Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
CLONEMESI is an academic, independent, randomized placebo-controlled trial to assess the
effect of transdermal (TD) clonidine in improving the symptoms of severe Hyperemesis
Gravidarum(HG) affecting women in their 6th-12th week of pregnancy. The study has a crossover
design.
Phase:
Phase 3
Details
Lead Sponsor:
Azienda Ospedaliera Città della Salute e della Scienza di Torino